Mackenzie Financial’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,945
Closed -$80K 1499
2022
Q2
$80K Sell
21,945
-3,538
-14% -$18K ﹤0.01% 1357
2022
Q1
$170K Buy
25,483
+10,730
+73% +$66.2K ﹤0.01% 1314
2021
Q4
$104K Buy
14,753
+577
+4% +$4.9K ﹤0.01% 1366
2021
Q3
$131K Sell
14,176
-317
-2% -$3.25K ﹤0.01% 1357
2021
Q2
$166K Buy
14,493
+229
+2% +$2.61K ﹤0.01% 1184
2021
Q1
$197K Buy
+14,264
New +$165K ﹤0.01% 1081
2020
Q4
Sell
-5,318
Closed -$23K 1080
2020
Q3
$23K Buy
5,318
+2,746
+107% +$14.3K ﹤0.01% 984
2020
Q2
$16K Buy
+2,572
New +$17.3K ﹤0.01% 999

Other funds holding OGI

Mackenzie Financial's OGI Position: Q3 2022 in Review

Mackenzie Financial sold out of Organigram Holdings (OGI) in Q3 2022, closing a stake of 21,945 shares — an estimated $80K sold.

Mackenzie Financial first reported a position in OGI in Q2 2020 and held it in 8 quarters. The position peaked at $197K in Q1 2021. 120 funds tracked by Wall St. Rank hold OGI as of Q3 2022.

  • Mackenzie Financial reported no remaining Organigram Holdings position as of Q3 2022 after selling out during the quarter.
  • Mackenzie Financial sold 21,945 Organigram Holdings shares in Q3 2022, an estimated $80K.
  • Mackenzie Financial first reported a position in Organigram Holdings in Q2 2020 and held it in 8 quarters.
  • Mackenzie Financial's Organigram Holdings position peaked at $197K in Q1 2021.
  • 120 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2022.

Based on Mackenzie Financial's 13F filing for Q3 2022, filed 7 Oct 2022.